Filing
Spy
Filing
Spy
Home
About
ZNTL — Zentalis Pharmaceuticals Inc - FilingSpy
ZNTL
Zentalis Pharmaceuticals Inc
Clinical-stage biopharmaceutical company
CUSIP: 98943L107
Healthcare
US
1 holder
Ownership
Activity
Fundamentals
2020 Q2
9 of 9 quarters
Total Value
$213.37M
Total Shares
4.44M
Net Share Change
+4.44M
Activity
1 buying
Investor
Value
Shares
Weight
Change
Viking Global Investors
$213.37M
4.44M
0.9%
NEW
Viking Global Investors
$213.37M
4.44M shares
NEW